Redox Regulation of the Glucocorticoid Receptor

Antioxidants and Redox Signaling

Volumn 1, Issue 4, 1999, Pages 403-423

  Tanaka, Hirotoshi ^a   Makino, Yuichi ^b   Okamoto, Kensaku ^b   Iida, Takahisa ^b   Yan, Kunimasa ^c   Yoshikawa, Noritada ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c KYORIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA BINDING PROTEIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; OXIDATION REDUCTION REACTION; PHYSIOLOGY; REVIEW; TWO HYBRID SYSTEM;

AMINO ACID SEQUENCE; ANIMALS; DNA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; RECEPTORS, GLUCOCORTICOID; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0033301258     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.1999.1.4-403     Document Type: Review

References (171)

1. ABATE, C., PATEL, L., RAUSCHER, F.J., III, and CURRAN, T. (1990). Redox regulation of Fos and Jun DNA-binding activity in vitro. Science 249, 1157-1161.
2. AKAMATSU, Y., OHNO, T., HIROTA, K., KAGOSHIMA, H., YODOI, J., and SHIGESADA, K. (1997). Redox regulation of the DNA binding activity in transcription factor PEBP2. J. Biol. Chem. 272, 14497-14502.
3. ALKSNIS, M., BARKHEM, T., STRÖMSTEDT, P.-E., AHOLA, H., KUTOH, E., GUSTAFSSON, J.-Å., POELLINGER, L., and NILSON, S. (1991). High level expression of functional full length and truncated glucocorticoid receptor in chinese hamster ovary cells. J. Biol. Chem. 266, 10078-10085.
4. AMMENDOLA, R., MESURACA, M., RUSSO, T., and CIMINO, F. (1994). The DNA-binding efficiency of Sp1 is affected by redox changes. Eur. J. Biochem. 225, 483-189.
5. ANDERSON, M.T., STAAL, F.J.T., GITLER, C., and HERZENBERG, L.A. (1994). Separation of oxidant-initiated and redox-regulated steps in the NF-κB signal transduction pathway. Proc. Natl. Acad. Sci. USA 91, 11527-11531.
6. ARNONE, M.I., ZANNINI, M., and LAURO, R.D. (1995). The DNA binding activity and the dimerization ability of the thyroid transcription factor I are redox regulated. J. Biol. Chem. 270, 12048-12055.
7. ASLUND, F., and BECKWITH, J. (1999). Bridge over troubled waters: sensing stress by disulfide bond formation. Cell 96, 751-753.
8. AYER, D.E. (1999). Histone deacetylases: transcriptional repression with SINers and NuRDs. Trends Cell Biol. 9, 193-198.
9. BAMBERGER, C.M., BAMBERGER, A.M., DE CASTRO, M., and CHROUSOS, G.P. (1995). Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95, 2435-2441.
10. BAMBERGER, C.M., ELSE, T., BAMBERGER, A.M., BEIL, F.U., and SCHULTE, H.M. (1997). Regulation of the human interleukin-2 gene by the alpha and beta isoforms of the glucocorticoid receptor. Mol. Cell Endocrinol. 136, 23-28.
11. BANDYOPADHYAY, S., and GRONOSTAJSKI, R.M. (1994). Identification of a conserved oxidation-sensitive cysteine residue in the NFI family of DNA-binding proteins. J. Biol. Chem. 269, 29949-29955.
12. BAUSKIN, A.R., AIKALAY, I., and BEN-NERIAH, Y. (1991). Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum. Cell 66, 685-696.
13. BEATO, M., HERRLICH, P., and SCHÜTZ, G. (1995). Steroid hormone receptors: many actors in search of a plot. Cell 83, 851-857.
14. BERK, A.J. (1999). Activation of RNA polymerase II transcription. Curr. Opin. Cell Biol. 11, 330-335.
15. BLAKE, M.J., UDELSMAN, R., FEULNER, G.J., NORTON, D.D., and HOLBROOK, N.J. (1991). Stress-induced heat shock protein 70 expression in adrenal cortex: an adrenocorticotropic hormone-sensitive, age-dependent response. Proc. Natl. Acad. Sci. USA 88, 9873-9877.
16. BLANCO, J.C., MINUCCI, S., LU, J., YANG, X.J., WALKER, K.K., CHEN, H., EVANS, R.M., NAKATANI, Y., and OZATO, K. (1998). The histone acetylase P/CAF is a nuclear receptor coactivator. Genes of Dev. 12, 1638-1651.
17. BODWELL, J.E., HOLBROOK, N.J., and MUNCK, A. (1984). Sulfhydryl-modifying reagents reversibly inhibit binding of glucocorticoid-receptor complexes to DNA-cellulose. Biochemistry 23, 1392-1398.
18. BOUMPAS, D.T., CHROUSUS, G.P., WILDER, R.L., CUPPS, T.R., and BALOW, J.E. (1993). NIH conference. Glucocorticoid therapy for immune-mediated diseases: basis and clinical correlates. Ann. Intern. Med. 119, 1198-1208.
19. BRZOZOWSKI, A.M., PIKE, A.C., DAUTER, Z., HUBBARD, R.E., BONN, T., ENGSTROM, O., OHMAN, L., GREENE, G.L., GUSTAFSSON J.-Å., and CARLQUIST, M. (1997). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753-758.
20. BUNONE, G., BRIAND, P.A., MIKSICEK, R.J., and PICARD, D. (1996). Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15, 2174-2183
21. CAPPEL, R.E., and GILBERT, H.F. (1988). Thiol/disulfide exchange between 3-hydroxy-3-methylglutaryl-CoA reductase and glutathione. J. Biol. Chem. 263, 12201-12212.
22. CARBALLO, M., CONDE, M., EL BEKAY, R., MARTINNIETO, J., CAMACHO, M.J., MONTESEIRIN, J., CONDE, J., BEDOYA, F.J., and SOBRINO, F. (1999). Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J. Biol. Chem. 274, 17580-17586.
23. CAREY, K.L., RICHARDS, S.A., LOUNSBURY, K.M., and MACARA, I.G. (1996). Evidence using a green fluorescent protein-glucocorticoid receptor chimera that the Ran/TC4 GTPase mediates an essential function independent of nuclear protein import. J. Cell Biol. 133, 985-996.
24. CARLSTEDT-DUKE, J., STROMSTEDT, P.E., PERSSON, B., CEDERLUND, E., GUSTAFSSON, J.-Å., and JORNVALL, H. (1988). Identification of hormone-interacting amino acid residues within the steroid-binding domain of the glucocorticoid receptor in relation to other steroid hormone receptors. J. Biol. Chem. 263, 6842-6846.
25. CATO, A.C.B., and WADE, E. (1996). Molecular mechanisms of anti-inflammatory action of glucocorticoids. BioEssays 18, 371-378.
26. CHAKRABORTI, P.K., GARABEDIAN, M.J., YAMAMOTO, K.R., and SIMONS, S.S., Jr. (1992). Role of cysteines 640, 656, and 661 in steroid binding to rat glucocorticoid receptor. J. Biol. Chem. 267, 11366-11373.
27. CHAKRAVARTI, D., LAMORTE, V.J., NELSON, M.C., NAKAJIMA, T., SCHULMAN, I.G., JUGUILON, H., MONTMINY, M., and EVANS, R.M. (1996). Role of CBP/P300 in nuclear receptor signalling. Nature 383, 99-103.
28. CHALFIE, M. (1995). Green fluorescent protein. Photochem. Photobiol. 162, 651-665.
29. CHEN, S., WANG, J., YU, G., LIU, W., and PEARCE, D. (1997). Androgen and glucocorticoid receptor heterodimer formation. A possible mechanism for mutual inhibition of transcriptional activity. J. Biol. Chem. 272, 14087-14092.
30. COHN, Z.A. (1978). Activation of mononuclear phagocytes: fact, fancy, and future. J. Immunol. 121, 813-816.
31. COLE, T.J., BLENDY, J.A., MONAGHAN, A.P., KRIEGLSTEIN, K., SCHMID, W., AGUZZI, A., FANTUZZI, G., HUMMLER, E., UNSICKER, K., and SCHUTZ, G. (1995). Targeted disruption of the gluco-corticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes & Dev. 9, 1608-1621.
32. DALTON, T.P., SHERTZER, H.G., and PUGA, A. (1999). Regulation of gene expression by reactive oxygen. Annu. Rev. Pharmacol. Toxicol. 39, 67-101.
33. DE CASTRO, M., ELLIOT, S., KINO, T., BAMBERGER, C., KARL, M., WEBSTER, E., and CHROUSOS, G.P. (1996). The non-ligand binding β-isoform of the human glucocorticoid receptor (hGRβ): tissue levels, mechanism of action, and potential physiologic role. Mol. Med. 2, 597-607.
34. DE LANGE, P., KOPER, J.W., HUIZENGA, N.A., BRINKMANN, A.O., DE JONG, F.H., KARL, M., CHROUSOS, G.P., and LAMBERTS, S.W. (1997). Differential hormone-dependent transcriptional activation and -repression by naturally occurring human glucocorticoid receptor variants. Mol. Endocrinol. 11, 1156-1164.
35. DEMPLE, B., and AMABILE-CUEVAS, C.F. (1991). Redox redux: the control of oxidative stress responses. Cell 67, 837-839.
36. DROUIN, J., SUN, Y.L., CHAMBERLAND, M., GAUTHIER, Y., DE LEAN, A., NEMER, M., and SCHMIDT, T.J. (1993). Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J. 12, 145-156.
37. EDWARDS, D.P. (1999). Coregulatory proteins in nuclear hormone receptor action. Vitam. Horm. 55, 165-218.
38. EMA, M., HIROTA, K., MIMURA, J., ABE, H., YODOI, J., SOGAWA, K., POELLINGER, L., and FUJIIKURIYAMA, Y. (1999). Molecular mechanisms of transcription activation by HLF and HIFlalpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 18, 1905-1914.
39. ESCRIVA, H., SAFI, R., HANNI, C., LANGLOIS, M.C., SAUMITOU-LAPRADE, P., STEHELIN, D., CAPRON, A., PIERCE, R., and LAUDET, V. (1997). Ligand binding was acquired during evolution of nuclear receptors. Proc. Natl. Acad. Sci. USA 94, 6803-6808.
40. ESPOSITO, F., CUCCOVILLO, F., MORRA, F., RUSSO, T., and CIMINO, F. (1995). DNA binding activity of the glucocorticoid receptor is sensitive to redox changes in intact cells. Biochim. Biophys. Acta. 1260, 308-314.
41. EVANS, R.M. (1988). The steroid and thyroid hormone receptor superfamily. Science 240, 889-895.
42. FENG, W., RIBEIRO, R.C., WAGNER, R.L., NGUYEN, H., APRILETTI, J.W., FLETTERICK, R.J., BAXTER, J.D., KUSHNER, P.J., and WEST, B.L. (1998). Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280, 1747-1749.
43. FONDELL, J.D., GUERMAH, M., MALIK, S., and ROEDER, R.G. (1999). Thyroid hormone receptor-associated proteins and general positive cofactors mediate thyroid hormone receptor function in the absence of the TATA box-binding protein-associated factors of TFIID. Proc. Natl. Acad. Sci. USA 96, 1959-1964.
44. FREEDMAN, L.P. (1999). Increasing the complexity of coactivation in nuclear receptor signaling. Cell 97, 5-8.
45. FREI, B. (1994). Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am. J. Med. 97 (Suppl. 3A), 5S-13S.
46. FRYER, C.J., and ARCHER, T.K. (1998). Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature 393, 88-91.
47. GAMALEY, I.A., and KLYUBIN, I.V. (1999). Roles of reactive oxygen species: signaling and regulation of cellular functions. Int. Rev. Cytol. 188, 203-255.
48. GASDASKA, J.R., KIRKPATRICK, D.L., MONTFORT, W., KUPERUS, M., HILL, S.R., BERGGREN, M., and POWIS, G. (1996). Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73→ Ser mutation. Biochem. Pharmacol. 52, 1741-1747.
49. GHADESSY, F.J., LIM, J., ABDULLAH, A.A., PANET-RAYMOND, V., CHOO, C.K., LUMBROSO, R., TUT, T.G., GOTTLIEB, B., PINSKY, L., TRIFIRO, M.A., and YONG, E.L. (1999). Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions. J. Clin. Invest. 103, 1517-1525.
50. GIGUERE, V., HOLLENBERG, S.M., ROSENFELD, M.G., and EVANS, R.M. (1986). Functional domains of the human glucocorticoid receptor. Cell 46, 645-652.
51. GLASS, K.C. (1994). Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Mol. Endocrinol. 15, 391-407.
52. GÖRNER, W., DURCHSCHLAG, E., MARTINEZ-PASTOR, M.T., ESTRUCH, F., AMMERE, G., HAMILTON, B., RUIS, H., and SCHULLER, C. (1998). Nuclear localization of the C2H2 zinc finger protein Msn2p is regulated by stress and protein kinase A activity. Genes & Dev. 12, 586-597.
53. GUEHMANN, S., VORBRUEGGEN, G., KALKBRENNER, F., and MOELLING, K. (1992). Reduction of a conserved Cys is essential for Myb DNA-binding. Nucleic Acids Res. 20, 2279-2286.
54. HAINAUT, P., and MILNER, J. (1993). Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res. 53, 4469-4473.
55. HALLIWELL, B., and GUTTERIDGE, J.M.C. (1989). Free Radicals in Biology and Medicine, 2nd ed. (Clarendon Press, Oxford).
56. HAMID, Q.A., WENZEL, S.E., HAUK, P.J., TSICOPOULOS, A., WALLAERT, B., LAFITTE, J.J., CHROUSOS, G.P., SZEFLER, S.J., and LEUNG, D.Y. (1999). Increased glucocorticoid receptor β in airway cells of glucocorticoid-insensitive asthma. Am. J. Respir. Crit. Care. Med. 159 (5 Pt. 1), 1600-1604.
57. HAYASHI, S.-I., HAJIRO-NAKANISHI, K., MAKINO, Y., EGUCHI, H., YODOI, J., and TANAKA, H. (1997). Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. Nucleic Acids Res. 25, 4035-4040.
58. HECHT, K., CARLSTEDT-DUKE, J., STIERNA, P., GUSTAFSSON, J.-Å., BRÖNNEGÅRD, M., and WIKSTROM, A.C. (1997). Evidence that the beta-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor. J. Biol. Chem. 272, 26659-26664.
59. HIROTA, K., MATSUI, M., IWATA, S., NISHIYAMA, A., MORI, K., and YODOI, J. (1997). AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA 94, 3633-3638.
60. HOLLENBERG, S.M., WEINBERGER, C., ONG, E.S., CERELLI, G., ORO, A., LEBO, R., THOMPSON, E.B., ROSENFELD, M.G., and EVANS, R.M. (1985). Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318, 635-641.
61. HOLMGREN, A. (1985). Thioredoxin. Annu. Rev. Biochem. 54, 237-271.
62. HOLMGREN, A. (1995). Thioredoxin structure and mechanism: conformational changes on oxidation of the active-site sulfhydryls to a disulfide. Structure 3, 239-243.
63. HÖRLEIN, A.J., NÄÄR, A.M., HEINZEL, T., TORCHIS, J., GLOSS, B., KUROKAWA, R., RYAN, A., KAMEI, Y., SÖRERSTRÖM, M., GLASS, C.K., and ROSENFELD, M.G. (1995). Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377, 397-404.
64. HSU, S., QI, M., and DEFRANCO, D.B. (1992). Cell cycle regulation of glucocorticoid receptor function. EMBO J. 11, 3457-3468.
65. HTUN, H., BARSONY, J., RENYI, I., GOULD, D.L., and HAGER, G.L. (1996). Visualization of glucocorticoid receptor translocation and intranuclear organization in living cells with a green fluorescent protein chimera. Proc. Natl. Acad. Sci. USA 93, 4845-4850.
66. HUANG, R., and ADAMSON, E.D. (1993). Characterization of the DNA-binding properties of the early growth response-1 (Egr-1) transcription factor: evidence for modulation by a redox mechanism. DNA Cell Biol. 12, 265-273.
67. HUTCHISON, K.A., MATIC, G., MESHINCHI, S., BRESNICK, E.H., and PRATT, W.B. (1991). Redox manipulation of DNA binding activity and BuGR epitope reactivity of the glucocorticoid receptor. J. Biol. Chem. 266, 10505-10509.
68. IRELAND, R.C., LI, S.-Y., and DOUGHERTY, J.J. (1995). The DNA binding of purified Ah receptor heterodimer is regulated by redox conditions. Arch. Biochem. Biophys. 319, 470-480.
69. JAYARAMAN, L., MURTHY, K.G., ZHU, C., CURRAN, T., XANTHOUDAKIS, S., and PRIVES, C. (1997). Identification of redox/repair protein Ref-1 as a potent activator pf p53. Genes & Dev. 11, 558-570.
70. JEWELL, C.M., WEBSTER, J.C., BURNSTEIN, K.L., SAR, M., BODWELL, J.E., and CIDLOWSKI, J.A. (1995). Immunocytochemical analysis of hormone mediated nuclear translocation of wild type and mutant glucocorticoid receptors. J. Steroid Biochem. Mol. Biol. 55, 135-146.
71. JOEL, P.B., TRAISH, A.M., and LANNIGAN, D.A. (1998a). Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J. Biol. Chem. 273, 13317-13323.
72. JOEL, P.B., SMITH, J., STURGILL, T.W., FISHER, T.L., BLENIS, J., and LANNIGAN, D.A. (1998b). pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167. Mol. Cell. Biol. 18, 1978-1984.
73. KALLIO, P.J., OKAMOTO, K., O'BRIEN, S., CARRERO, P., MAKINO, Y., TANAKA, H., and POELLINGER, L. (1998). Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1α. EMBO J. 17, 6573-6586.
74. KAMATA, H., and HIRATA, H. (1999). Redox regulation of cellular signalling. Cell Signal. 11, 1-14.
75. KAMBE, F., NOMURA, Y., OKAMOTO, T., and SEO, H. (1996). Redox regulation of thyroid-transcription factors, Pax-8 and TTF-1, is involved in their increased DNA-binding activities by thyrotropin in rat thyroid FRTL-5 cells. Mol. Endocrinol. 10, 801-812.
76. KAMEI, Y., XU, L., HEINZEL, T., TORCHIA, J., KUROKAWA, R., GLOSS, B., LIN, S.C., HEYMAN, R.A., ROSE, D.W., GLASS, C.K., and ROSENFELD, M.G. (1996). A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414.
77. KANG, K.I., MENG, X., DEVIN-LECLERC, J., BOUHOUCHE, I., CHADLI A., CADEPOND, F., BAULIEU, E.E., and CATELLI, M.G. (1999). The molecular chaperone Hsp90 can negatively regulate the activity of a glucocorticosteroid-dependent promoter. Proc. Natl. Acad. Sci. USA 96, 1439-1444.
78. KATO, S., ENDOH, H., MASUHIRO, Y., KITAMOTO, T., UCHIYAMA, S., SASAKI, H., MASUSHIGE, S., GOTOH, Y., NISHIDA, E., KAWASHIMA, H., and CHAMBON, P. (1995). Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270, 1491-1494.
79. KATZENELLENBOGEN, J.A., O'MALLEY, B.W., and KATZELLENBOGEN, B.S. (1996). Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell-and promoter-specific action of these hormones. Mol. Endocrinol. 10, 119-131.
80. KORTHUIS, R.J., and GRANGER, D.N. (1986). In Physiology of Oxygen Radicals. A.E. Taylor, S. Matalon, and P.A. Wrad, (eds.). (Williams and Wilkins, Baltimore) pp. 217-249.
81. KRSTIC, M.D., ROGATSKY, I., YAMAMOTO, K.R., and GARABEDIAN, M.J. (1997). Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol. Cell. Biol. 17, 3947-3954.
82. KUGE, S., JONES, N., and NOMOTO, A. (1997). Regulation of yAP-1 nuclear localization in response to oxidative stress. EMBO J. 16, 1710-1720.
83. LANZ, R.B., MCKENNA, N.J., ONATE, S.A., ALBRECHT, U., WONG, J., TSAI, S.Y., TSAI, M.J., and O'MALLEY, B.W. (1999). A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97, 17-27.
84. LEPPA, S., PIRKKALA, L., CHOW, S.C., ERIKSSON, J.E., and SISTONEN, L. (1997). Thioredoxin is transcriptionally induced upon activation of heat shock factor 2. J. Biol. Chem. 272, 30400-30404.
85. LEUNG, D.Y.M., HAMID, Q., VOTTERO, A., SZEFLER, S.J., SURS, W., MINSHALL, E., CHROUSOS, G.P., and KLEMM, D.J. (1997). Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor β. J. Exp. Med. 186, 1567-1574.
86. LIU, W., WANG, J., SAUTER, N.K., and PEARCE, D. (1995). Steroid receptor heterodimerization demonstrated in vitro and in vivo. Proc. Natl. Acad. Sci. USA 92, 12480-12484.
87. LUISI, B.F., XU, W.X., OTWINOWSKI, Z., FREEDMAN, L.P., YAMAMOTO, K.R., and SIGLER, P.B. (1991). Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352, 497-505.
88. MA, J., and PTASHNE, M. (1987). A new class of yeast transcriptional activators. Cell 51, 113-119.
89. MADAN, A.P., and DEFRANCO, D.B. (1993). Bidirectional transport of glucocorticoid receptors across the nuclear envelope. Proc. Natl. Acad. Sci. USA 90, 3588-3592.
90. MAKINO, Y., OKAMOTO, K., YOSHIKAWA, N., AOSHIMA, M., HIROTA, K. YODOI, J., UMESONO, K., MAKINO, I., and TANAKA, H. (1996a). Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system. J. Clin. Invest. 98, 2469-2477.
91. MAKINO, Y., TANAKA, H., DAHLMAN-WRIGHT, K., and MAKINO, I. (1996b). Modulation of glucocorticoid-inducible gene expression by metal ions. Mol. Pharmacol. 49, 612-620.
92. MAKINO, Y., YOSHIKAWA, N., OKAMOTO, K., HIROTA, K., YODOI, J., MAKINO, I., and TANAKA, H. (1999). Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function. J. Biol. Chem. 274, 3182-3188.
93. MANGELSDORF, D.J., THUMMEL, C., BEATO, M., HERRLICH, P., SCHÜTZ, G., UMESONO, K., BLUMBERG, B., KASTNER, P., MARK, M., CHAMBON, P., and EVANS, R.M. (1995). The nuclear receptor superfamily: the second decade. Cell 83, 835-839.
94. MASUTANI, H., HIROTA, K., SASADA, T., UEDA-TANIGUCHI, Y., TANIGUCHI, Y., MATSUI, M., and YODOI, J. (1996). Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I Tax. Immunol. Lett. 54, 67-71.
95. MATSUI, M., OSHIMA, M., OSHIMA, H., TAKAKU, K., MARUYAMA, T. YODOI, J., and TAKETO, M.M. (1996). Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev. Biol. 178, 179-185.
96. McBRIDE, A.A., KLAUSNER, R.D., and HOWLEY, P.M. (1992). Conserved cysteine residue in the DNA-binding domain of the bovine papillomavirus type 1 E2 protein confers redox regulation of the DNA-binding activity in vitro. Proc. Natl. Acad. Sci. USA 89, 7531-7535.
97. MCCORD, J.M. (1987). Oxygen-derived free radicals: a link between reperfusion injury and inflammation. Fed. Proc. 46, 2401-2406.
98. MEYER, M., SCHRECK, R., and BAEUERLE, P.A. (1993). H2O2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12, 2005-2015.
99. MOILANEN, A.-M., POUKKA, H., KARVONEN, U., JÄNNE, O.A., and PALVIMO, J.J. (1998). Activation of androgen receptor function by a novel nuclear protein kinase. Mol. Cell. Biol. 18, 5128-5139.
100. MUNCK, A., GUYRE, P.M., and HOLBROOK, N.J. (1984). Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrine Rev. 5, 25-14.
101. MYRSET, A.H., BOSTAD, A., JAMIN, N., LIRSAC, P.-N., TOMA, F., and GABRIELSEN, O.S. (1993). DNA and redox state induced conformational changes in the DNA-binding domain of the Myb oncoprotein. EMBO J. 12, 4625-4633.
102. NAKAMURA, H., NAKAMURA, K., and YODOI, J. (1997). Redox regulation of cellular activation. Annu. Rev. Immunol. 15, 351-369.
103. NAKSHATRI, H., BHAT-NAKSHATRI, P., and CURRIE, R.A. (1996). Subunit association and DNA binding activity of the heterotrimeric transcription factor NF-Y is regulated by cellular redox. J. Biol. Chem. 271, 28784-28792.
104. NIGG, E.A. (1997). Nucleocytoplasmic transport: signals, mechanisms and regulation. Nature 386, 779-787.
105. NUCLEAR RECEPTOR NOMENCLATURE COMMITTEE. (1999). A unified nomenclature system for the nuclear receptor superfamily. Cell 97, 161-163.
106. OAKLEY, R.H., SAR, M., and CIDLOWSKI, J.A. (1996). The human glucocorticoid receptor β isoform. Expression, biochemical properties, and putative function. J. Biol. Chem. 271, 9550-9559.
107. OAKLEY, R.H., WEBSTER, J.C., SAR, M., PARKER, C.R., JR., and CIDLOWSKI, J.A. (1997). Expression and subcellular distribution of the β-isoform of the human glucocorticoid receptor. Endocrinology 138, 5028-5038.
108. OGAWA, H., INOUYE, S., TSUJI, F.I., YASUDA, K., and UMESONO, K. (1995). Localization, trafficking, and temperature-dependence of the Aequorea green fluorescent protein in cultured vertebrate cells. Proc. Natl. Acad. Sci. USA 92, 11899-11903.
109. OGRYZKO, V.V., SCHILTZ, R.L., RUSSANOVA, V., HOWARD, B.H., and NAKATANI, Y. (1996). The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-959.
110. OKAMOTO, K., TANAKA, H., MAKINO, Y., and MAKINO, I. (1998). Restoration of the glucocorticoid receptor function by the phosphodiester compound of vitamins C and E, EPC-K1 (L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran- 6-yl hydrogen phosphate] potassium salt), via a redox-dependent mechanism. Biochem. Pharmacol. 56, 79-86.
111. OKAMOTO, K., TANAKA, H., OGAWA, H., MAKINO, Y., EGUCHI, H., HAYASHI, S., YOSHIKAWA, N., POELLINGER, L., UMESONO, K., and MAKINO, I. (1999). Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J. Biol. Chem. 274, 10363-10371.
112. OKAMOTO, T., OGIWARA, H., HAYASHI, T., MITSUI, A., KAWABE, T., and YODOI, J. (1992). Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism. Intern. Immunol. 4, 811-819.
113. ONATE, S.A., TSAI, S.Y., TSAI, M.-J., and O'MALLEY, B.W. (1995). Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270, 1354-1357.
114. OTTO, C., REICHARDT, H.M., and SCHUTZ, G. (1997). Absence of glucocorticoid receptor-β in mice. J. Biol. Chem. 272, 26665-26668.
115. PICARD, D., and YAMAMOTO, K.R. (1987). Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J. 6, 3333-3340.
116. POGNONEC, P., KATO, H., and ROEDER, R.G. (1992). The helix-loop-helix repeat transcription factor USF can be functionally regulated in a redox-dependent manner. J. Biol. Chem. 267, 24563-24567.
117. PRATT, W.B. (1993). The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J. Biol. Chem. 268, 21455-21458.
118. PRINZ, W.A., ÅSLUND, F., HOLMGREN, A., and BECKWITH, J. (1997). The role of the thioredoxin and glutare-doxin pathways in reducing protein disulfide bonds in the Escherichia coli cytoplasm. J. Biol. Chem. 272, 15661-15667.
119. QIN, J., CLORE, G.M., KENNEDY, W.P., KUSZEWSKI, J., and GRONENBORN, A.M. (1995). Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF-κB. Structure 3, 289-297.
120. QIN, J., CLORE, G.M., KENNEDY, W.P., KUSZEWSKI, J., and GRONENBORN, A.M. (1996). The solution structure of human thioredoxin complexed with its target from Ref-1 reveals peptide chain reversal. Structure 4, 613-620.
121. RACHEZ, C., SULDAN, Z., WARD, J., CHANG, C.P., BURAKOV, D., ERDJUMENT-BROMAGE, H., TEMPST, P., and FREEDMAN, L.P. (1998). A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes & Dev. 12, 1787-1800.
122. RACHEZ, C., LEMON, B.D., SULDAN, Z., BROMLEIGH, V., GAMBLE, M., NAAR, A.M., ERDJUMENT-BROMAGE, H., TEMPST, P., and FREEDMAN, L.P. (1999). Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398, 824-828.
123. RAINWATER, R., PARKS, D., ANDERSON, M.E., TEGTMEYER, P., and MANN, K. (1995). Role of cysteine residues in regulation of p53 function. Mol. Cell. Biol. 15, 3892-3903.
124. RANGARAJAN, P.N., UMESONO, K., and EVANS, R.M. (1992). Modulation of glucocorticoid receptor function by protein kinase A. Mol. Endocrinol. 6, 1451-1457.
125. REICHARDT, H.M., KAESTNER, K.H., TUCKERMANN, J., KRETZ, O., WESSELY, O., BOCK, R., GASS, P., SCHMID, W., HERRLICH, P., ANGEL, P., and SCHÜTZ, G. (1998). DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93, 531-541.
126. RHEE, S.G. (1999). Redox signaling: hydrogen peroxide as intracellular messenger. Exp. Mol. Med. 31, 53-59.
127. ROGATSKY, I., WAASE, C.L., and GARABEDIAN, M.J. (1998). Phosphorylation and inhibition of rat glucocorticoid receptor transcriptional activation by glycogen synthase kinase-3 (GSK-3). Species-specific differences between human and rat glucocorticoid receptor signaling as revealed through GSK-3 phosphorylation. J. Biol. Chem. 273, 14315-14321.
128. SACKEY, F.N.A., HACHE, R.J.G., REICH, T., KWASTWELFELD, J., and LEFEBVRE, Y.A. (1996). Determinants of subcellular distribution of the glucocorticoid receptor. Mol. Endocrinol. 10, 1191-1205.
129. SAITOH, M., NISHITOH, H., FUJII, M., TAKEDA, K., TOBIUME, K., SAWADA, Y., KAWABATA, M., MIYAZONO, K., and ICHIJO, H. (1998). Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17, 2596-2606.
130. SCHEIDEREIT, C., WESTPHAL, H.M., CARLSON, C., BOSSHARD, H., and BEATO, M. (1986). Molecular model of the interaction between the glucocorticoid receptor and the regulatory elements of inducible genes. DNA 5, 383-391.
131. SCHENA, M., FREEDMAN, L.P., and YAMAMOTO, K.R. (1989). Mutations in the glucocorticoid receptor zinc finger region that distinguish interdigitated DNA binding and transcriptional enhancement activities. Genes & Dev. 3, 1590-1601.
132. SCHENK, H., KLEIN, M., ERDBRUGGER, W., DRÖGE, W., and SCHULZE-OSTHOFF, K. (1994). Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc. Natl. Acad. Sci. USA 91, 1672-1676.
133. SCHRECK, R., MEIER, B., MANNEL, D.N., DROGE, W., and BAEUERIE, P.A. (1992). Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175, 1181-1194.
134. SCHRECK, R., and BAEUERLE, P.A. (1994). Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-κB. Methods Enzymol. 234, 151-163.
135. SCHRECK, R., RIEBER, P., and BAEUERLE, P.A. (1991). Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10, 2247-2258.
136. SCHULZE-OSTHOFF, K., BAUER, M.K., VOGT, M., and WESSELBORG, S. (1997). Oxidative stress and signal transduction. Int. J. Vitam. Nutr. Res. 67, 336-342.
137. SELYE, H. (1946). The general adaptation syndrome and the diseases of adaptation. J. Clin. Endocrinol. Metab. 6, 117-230.
138. SEN, C.K. (1998). Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem. Pharmacol. 55, 1747-1758.
139. SEVERNE, Y., WIELAND, S., SCHAFFNER, W., and RUSCONI, S. (1988). Metal binding 'finger' structures in the glucocorticoid receptor defined by site-directed mutagenesis. EMBO J. 7, 2503-2508.
140. SHAHIDI, H., VOTTERO, A., STRATAKIS, C.A., TAYMANS, S.E., KARL, M., LONGUI, C.A., CHROUSOS, G.P., DAUGHADAY, W.H., GREGORY, S.A., and PLATE, J.M. (1999). Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem. Biophys. Res. Commun. 254, 559-565.
141. SHAO, D., and LAZAR, M.A. (1999). Modulating nuclear receptor function: may the phos be with you. J. Clin. Invest. 103, 1617-1618.
142. SHIAU, A.K., BARSTAD, D., LORIA, P.M., CHENG, L., KUSHNER, P.J., AGARD, D.A., and GREENE, G.L. (1998). The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95, 927-937.
143. SIES, H. (1997). Oxidative stress: oxidants and antioxidants. Exp. Physiol. 82, 291-295.
144. SILVA, C.M., and CIDLOWSKI, J.A. (1989). Direct evidence for intra-and intermolecular disulfide bond formation in the human glucocorticoid receptor. Inhibition of DNA binding and identification of a new receptor-associated protein. J. Biol. Chem. 264, 6638-6647.
145. SIMONS, S.S., JR., and PRATT, W.B. (1995). Glucocorticoid receptor thiols and steroid-binding activity. Methods Enzymol. 251, 406-422.
146. SNYDER, G.H., CENNERAZZO, M.J., KARALIS, A.J., and FIELD. D. (1981). Electrostatic influence of local cysteine environments on disulfide exchange kinetics. Biochemistry 20, 6509-6518.
147. STORZ, G., TARTAGLIA, L.A., and AMES, B.N. (1990). Transcriptional regulation of oxidative stress-inducible genes: direct activation by oxidation. Science 248, 189-194.
148. TANAKA, H., MAKINO, Y., and OKAMOTO, K. (1999). Thioredoxin in the endocrine response to stress. Vitam. Horm. 57, 153-175.
149. TANENBAUM, D.M., WANG, Y., WILLIAMS, S.P., and SIGLER, P.B. (1998). Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc. Natl. Acad. Sci. USA 95, 5998-6003.
150. TANG, Y., and DEFRANCO, D.B. (1996). ATP-dependent release of glucocorticoid receptors from the nuclear matrix. Mol. Cell Biol. 16, 1989-2001.
151. TANG, Y., RAMAKRISHNAN, C., THOMAS, J., and DEFRANCE, D.B. (1997). A role for HDJ-2/HSDJ in correcting subnuclear trafficking, transactivation, and transrepression defects of a glucocorticoid receptor zinc finger mutant. Mol. Biol. Cell 8, 795-809.
152. TOLEDANO, M.B., and LEONARD, J.W. (1991). Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. USA 88, 4328-4332.
153. TREMBLAY, A., TREMBLAY, G.B., LABRIE, F., and GIGUERE, V. (1999). Ligand-independent recruitment of SRC-1 to estrogen receptor β through phosphorylation of activation function AF-1. Mol. Cell 3, 513-519.
154. TSIEN, R.Y. (1998). The green fluorescent protein. Annu. Rev. Biochem. 67, 509-544.
155. UMESONO, K., and EVANS, R.M. (1989). Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 57, 1139-1146.
156. VERHAEGH, G.W., RICHARD, M.-J., and HAINAUT, P. (1997). Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper. Mol. Cell. Biol. 17, 5699-5706.
157. WANG, W., COTE, J., XUE, Y., ZHOU, S., KHAVARI, P.A., BIGGAR, S.R., MUCHARDT, C., KALPANA, G.V., GOFF, S.P., YANIV, M., WORKMAN, J.L., and CRABTREE, G.R. (1996). Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J. 15, 5370-5382.
158. WASYLYK, C., and WASYLYK, B. (1993). Oncogenic conversion of Ets affects redox regulation in vivo and in vitro. Nucleic Acids Res. 21, 523-529.
159. WU, X., BISHOPRIC, N.H., DISCHER, D.J., MURPHY, B.J., and WEBSTER, K.A. (1996). Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol. Cell. Biol. 16, 1035-1046.
160. WURTZ, J.M., EGNER, U., HEINRICH, N., MORAS, D., and MUELLER-FAHRNOW, A. (1998). Three-dimensional models of estrogen receptor ligand binding domain complexes based on related crystal structures and mutational and structure-activity relationship data. J. Med. Chem. 41, 1803-1814.
161. XANTHOUDAKIS, S., MIAO, G., WANG, F., PAN, Y.E., and CURRAN, T. (1992). Redox activation of Fos-Jun binding activity is mediated by a DNA repair enzyme. EMBO J. 11, 3323-3335.
162. XANTHOUDAKIS, S., MIAO, G.G., and CURRAN, T. (1994). The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. Proc. Natl. Acad. Sci. USA 91, 23-27.
163. XU, L., GLASS, C.K., and ROSENFELD, M.G. (1999). Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9, 140-147.
164. XU, M., DITTMAR, K.D., GIANNOUKOS, G., PRATT, W.B., and SIMONS, S.S. JR. (1998). Binding of hsp90 to the glucocorticoid receptor requires a specific 7-amino acid sequence at the amino terminus of the hormone-binding domain. J. Biol. Chem. 273, 13918-13924.
165. YANG, J., and DEFRANCO, D.B. (1996). Assessment of glucocorticoid receptor-heat shock protein 90 interactions in vivo during nucleocytoplasmic trafficking. Mol. Endocrinol. 10, 3-13.
166. YANG, J., LIU, J., and DEFRANCO, D.B. (1997). Subnuclear trafficking of glucocorticoid receptors in vitro: chromatin recycling and nuclear export. J. Cell Biol. 137, 523-538.
167. YAO, T.P., KU, G., ZHOU, N., SCULLY, R., and LIVINGSTON, D.M. (1996). The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. Natl. Acad. Sci. USA 93, 10626-10631.
168. YU, B.P. (1994). Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 74, 139-162.
169. YUAN, C.X., ITO, M., FONDELL, J.D., FU, Z.Y., and ROEDER, R.G. (1998). The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc. Natl. Acad. Sci. USA 95, 7939-7944.
170. ZHAO, K., WANG, W., RANDO, O.J., XUE, Y., SWIDEREK, K., KUO, A., and CRABTREE, G.R. (1998). Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell 95, 625-636.
171. ZILLIACUS, J., DAHLMAN-WRIGHT, K., CARLSTEDT-DUKE, J., and GUSTAFSSON, J.-Å. (1992). Zinc coordination scheme for the C-terminal zinc binding site of nuclear hormone receptors. J. Steroid Biochem. Mol. Biol. 42, 131-139.